GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mezzion Pharma Co (XKRX:140410) » Definitions » Cyclically Adjusted Book per Share

Mezzion Pharma Co (XKRX:140410) Cyclically Adjusted Book per Share : ₩2,298.91 (As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Mezzion Pharma Co Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Mezzion Pharma Co's adjusted book value per share for the three months ended in Mar. 2024 was ₩1,940.787. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₩2,298.91 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Mezzion Pharma Co's average Cyclically Adjusted Book Growth Rate was -100.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2024-05-22), Mezzion Pharma Co's current stock price is ₩37500.00. Mezzion Pharma Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was ₩2,298.91. Mezzion Pharma Co's Cyclically Adjusted PB Ratio of today is 16.31.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Mezzion Pharma Co was 29.87. The lowest was 5.00. And the median was 14.99.


Mezzion Pharma Co Cyclically Adjusted Book per Share Historical Data

The historical data trend for Mezzion Pharma Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mezzion Pharma Co Cyclically Adjusted Book per Share Chart

Mezzion Pharma Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 2,534.15 2,439.15 2,337.81

Mezzion Pharma Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,396.40 2,375.51 2,380.06 2,337.81 2,298.91

Competitive Comparison of Mezzion Pharma Co's Cyclically Adjusted Book per Share

For the Drug Manufacturers - General subindustry, Mezzion Pharma Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mezzion Pharma Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mezzion Pharma Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Mezzion Pharma Co's Cyclically Adjusted PB Ratio falls into.



Mezzion Pharma Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Mezzion Pharma Co's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1940.787/118.8477*118.8477
=1,940.787

Current CPI (Mar. 2024) = 118.8477.

Mezzion Pharma Co Quarterly Data

Book Value per Share CPI Adj_Book
201406 2,770.546 99.353 3,314.173
201409 2,917.133 99.608 3,480.589
201412 2,895.113 99.098 3,472.093
201503 0.000 99.720 0.000
201506 0.000 100.050 0.000
201509 0.000 100.110 0.000
201512 2,828.488 100.220 3,354.214
201603 2,685.317 100.560 3,173.665
201606 2,542.355 100.790 2,997.847
201609 2,380.248 101.460 2,788.163
201612 2,388.524 101.560 2,795.102
201703 2,238.205 102.850 2,586.344
201706 2,201.036 102.610 2,549.343
201709 1,989.082 103.490 2,284.258
201712 2,233.768 102.990 2,577.708
201803 2,214.239 104.100 2,527.927
201806 1,848.899 104.130 2,110.222
201809 2,210.719 105.650 2,486.880
201812 2,225.924 104.350 2,535.179
201903 2,305.359 104.490 2,622.132
201906 2,145.902 104.880 2,431.689
201909 2,028.019 105.200 2,291.116
201912 1,639.875 105.120 1,854.028
202003 1,461.574 105.540 1,645.866
202006 1,278.499 104.870 1,448.905
202009 1,097.893 106.200 1,228.645
202012 2,129.452 105.765 2,392.847
202103 1,842.998 107.357 2,040.255
202106 1,899.662 107.579 2,098.656
202109 1,773.543 108.759 1,938.057
202112 2,351.552 109.676 2,548.192
202203 2,189.240 111.806 2,327.126
202206 1,464.654 114.083 1,525.828
202209 1,272.458 114.831 1,316.964
202212 981.230 115.200 1,012.298
202303 817.322 116.550 833.438
202306 2,266.537 117.140 2,299.581
202309 2,159.176 119.111 2,154.399
202312 2,075.304 118.848 2,075.304
202403 1,940.787 118.848 1,940.787

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Mezzion Pharma Co  (XKRX:140410) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Mezzion Pharma Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=37500.00/2298.91
=16.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Mezzion Pharma Co was 29.87. The lowest was 5.00. And the median was 14.99.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Mezzion Pharma Co Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Mezzion Pharma Co's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Mezzion Pharma Co (XKRX:140410) Business Description

Industry
Traded in Other Exchanges
N/A
Address
C&H, Samseong-dong, 154-8, Gangnam-gu, Dongdaemun-gu, Seoul, KOR, 135-879
Mezzion Pharma Co is a South Korea based drug manufacturer company. It develops and manufactures pharmaceutical products for erectile dysfunction and benign prostatic hyperplasia.

Mezzion Pharma Co (XKRX:140410) Headlines

No Headlines